See Clearly with Clearside Biomedical: Exciting Presentations at the American Academy of Ophthalmology 2023 Annual Meeting!
Clinical Data Utilizing Clearside’s Suprachoroidal Delivery Technology to be Featured in Multiple Presentations ALPHARETTA, Ga., Nov. 02, 2023 (GLOBE NEWSWIRE) — Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS®), announced today that multiple oral and poster presentations have been…